Xiaofei Zhou
Overview
Explore the profile of Xiaofei Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
159
Citations
2668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez M, Yang Z, Schelman W, Zhou X, Gupta N, Chien C
Clin Transl Sci
. 2025 Mar;
18(3):e70168.
PMID: 40077903
This two-sequence, three-period study (NCT04645940) was designed to evaluate the effect of food and concomitant rabeprazole, a proton pump inhibitor, on the pharmacokinetics (PK) and safety of fruquintinib and its...
2.
Zhu X, Zhao Z, Zhang Y, Li H, Zhou X, Zhu Y, et al.
Cell Signal
. 2025 Mar;
:111728.
PMID: 40074192
Ischemic stroke, a neurological condition with a complicated etiology that is accompanied by severe inflammation and oxidative stress, and ethanol (EtOH) may aggravate ischemia/reperfusion (I/R)-induced brain damage. However, the effect...
3.
Bao L, Zhou X, Zheng B, Cong R, Yin H, Zhang J, et al.
IEEE Trans Image Process
. 2025 Mar;
PP.
PMID: 40031013
Visible-depth-thermal (VDT) salient object detection (SOD) aims to highlight the most visually attractive object by utilizing the triple-modal cues. However, existing models don't give sufficient exploration of the multi-modal correlations...
4.
Zhou X, Yang X, Grinshpun B, Taylor A, Strong L, Dasari A, et al.
J Clin Pharmacol
. 2025 Feb;
PMID: 39969131
Fruquintinib is a selective, oral tyrosine kinase inhibitor of all three vascular endothelial growth factor receptors 1, 2, and 3, which is approved for patients with previously treated metastatic colorectal...
5.
Zhou X, Zang N, Yang T, Jia J, Zhou H, Jia J
Acta Biomater
. 2025 Jan;
194:455-466.
PMID: 39864642
For biomedical applications, two-dimensional transition metal dichalcogenides (2D TMDCs) are often combined with other elements or functionalized with specific surface ligands, while their intrinsic biological activities are not yet fully...
6.
Li L, Wei N, Guo Y, Zhu X, Wang L, Zhu Y, et al.
Mikrochim Acta
. 2024 Dec;
192(1):5.
PMID: 39630274
An ultra-sensitive photoelectrochemical (PEC) biosensor for amyloid-beta 40 (Aβ40), a biomarker for Alzheimer's disease (AD), was developed using g-C₃N₄ modified with gold nanoparticles (Au NPs) to form Au-C₃N₄. This was...
7.
van Eeghen C, Soucie J, Clifton J, Hitt J, Mollis B, Rose G, et al.
BMC Health Serv Res
. 2024 Nov;
24(1):1361.
PMID: 39511571
Background: Integrating behavioral health services in primary care is challenging; a toolkit approach to practice implementation can help. A recent comparative effectiveness randomized clinical trial examined the impact of a...
8.
Wang Z, Ju S, Zhou X, Ni F, Qiu Y, Zhang R, et al.
Anal Bioanal Chem
. 2024 Sep;
416(28):6259-6267.
PMID: 39289204
Raman spectroscopy is an important technique for analyzing the chemical composition of samples in many fields. A severe challenge often encountered in Raman measurements is the presence of a concurrent...
9.
Feng Z, Li S, Gu T, Zhou X, Zhang Z, Yang Z, et al.
Molecules
. 2024 Aug;
29(16).
PMID: 39203059
In the original publication [...].
10.
Ercan C, Kordy K, Knuuttila A, Zhou X, Kumar D, Koponen V, et al.
Virchows Arch
. 2024 Jun;
485(6):1095-1105.
PMID: 38879691
Histological assessment of autoimmune hepatitis (AIH) is challenging. As one of the possible results of these challenges, nonclassical features such as bile-duct injury stays understudied in AIH. We aim to...